Photodynamic Therapy-Current Limitations and Novel Approaches.
Gunaydin G, Gedik ME, Ayan S. · 2021
Read Photodynamic Therapy-Current Limitations and Novel Approaches. by Gunaydin G, Gedik ME, Ayan S. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8223074.txt.
Description
Gunaydin, Gedik, and Ayan assess photodynamic therapy, its limits, and new approaches. The therapy excites a light-sensitive drug to make singlet oxygen. That burst kills target tumour cells.
Early uses date to the 1900s, with tumour treatment reported in 1978. A first drug won FDA approval in 1995. The method suits several malignant diseases and harms healthy tissue little. Limits include light reach and oxygen supply in tumours. The authors survey fresh ways around those limits. New sensitizers and delivery routes lead the list. Its safety profile counts among the method's known strengths.
Catalog record
| CREATOR | Gunaydin G, Gedik ME, Ayan S. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 146 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |